Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response.
about
Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.Diagnostic value of urinary-to-serum human epididymis protein 4 ratio in ovarian cancer.Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disordersM-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patientsDiscrepant clinicopathologic characteristics and HE4 performance in type I and type II epithelial ovarian cancer.Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancerThe use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer.The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors.The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer.Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis.The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer.The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.Serum tumor markers in chronic kidney disease: as clinical tool in diagnosis, treatment and prognosis of cancers.Evaluating the clinical significances of serum HE4 with CA125 in peritoneal tuberculosis and epithelial ovarian cancer.Clinical value of combining transvaginal contrast-enhanced ultrasonography with serum human epididymisprotein-4 and the resistance index for early-stage epithelial ovarian cancer.KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis.HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.
P2860
Q32173966-B34D98BE-8B13-44F2-AC9A-366125277C88Q33857804-AC2F024C-6818-408D-9BCF-2B1188036D38Q35207172-FD41A2C2-DBA0-48F6-89EC-CAC5E1CDF2A4Q35589339-5352C077-FC84-42D5-AA1A-94A63493F6D5Q35925743-7FB08959-5D1C-4C27-971F-AFBF5ECC3FECQ36729517-BBAE2D5A-3100-4517-B2B6-E3A69319964FQ36982622-1F4CA69F-181C-46B0-AF18-F80F32BCD77DQ36996525-E58FCD86-F7F7-47F7-A821-04C239925507Q37001660-13B018B5-0086-49B6-98C9-2BFE09026F5AQ37053905-645615A9-081E-47D9-A202-B4CB8BEDA772Q38388103-DC7B2EBE-FD77-4106-A37F-58AB9B6380AAQ38653169-D4127DFA-75B0-445A-9C08-31779ADE7730Q38747437-582CE2D5-58A4-4009-8BEC-93F3FCEB5094Q40212320-A3E89C16-FDBB-45C8-92EC-39461D7F1BEBQ41223900-79844261-DA97-49F5-AECD-C962628B2BC5Q48628148-2A869405-E303-44B1-AD05-22FB50C90EEEQ55430421-AA14D5C0-5A27-4696-B779-35BC6BBB84E7
P2860
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Significance of HE4 estimation ...... essment of treatment response.
@en
type
label
Significance of HE4 estimation ...... essment of treatment response.
@en
prefLabel
Significance of HE4 estimation ...... essment of treatment response.
@en
P2093
P2860
P356
P1433
P1476
Significance of HE4 estimation ...... essment of treatment response.
@en
P2093
Abeer M Mohammed
Ali A Abd-Alla
Elham O Hamed
Hazem M Abdel Ghaffar
Hydi Ahmed
Osama B Sedeek
P2860
P2888
P356
10.1186/1746-1596-8-11
P577
2013-01-23T00:00:00Z
P5875
P6179
1036620129